Latest Breaking News On - Ronald van vollenhoven - Page 1 : comparemela.com

Choose wisely : Each biologic for lupus has ideal patient profile

Choose wisely : Each biologic for lupus has ideal patient profile
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Noord hollandRonald van vollenhovenJustin cooper healioShenaz baghaByjustin cooperAmsterdam university medical centerClinical rheumatologyJustin cooper

CAR T-cell therapy remains the hottest story in lupus, autoimmune disease

CAR T-cell therapy remains the hottest story in lupus, autoimmune disease
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Noord hollandByrob volanskyShenaz baghaRonald van vollenhovenAmsterdam medical centerAmsterdam rheumatology center academic medicalClinical rheumatologyJason laday

Congress of Clinical Rheumatology-East celebrates milestone 40th anniversary

Congress of Clinical Rheumatology-East celebrates milestone 40th anniversary
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of pennsylvaniaNoord hollandUniversity of floridaSandestin hiltonRuth ann vleugelsShenaz baghaMike lewieckiJason busseAnne marie malfaitVan vollenhovenAlexis ogdie beattyDavida mclainMegan eb clowseDoruk erkanPhilip seo

Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

Noord hollandSharon barrRonald van vollenhovenAmsterdam rheumatology centerExecutive vice president

Promising Telitacicept Results Reported for Lupus, Sjögren s

Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept, compared with placebo.

University medical centerUnited statesNoord hollandUniversity of texas southwestern medical centerRoy fleischmannVan vollenhovenBristol myers squibbRonald van vollenhovenEuropean congressVu university medical centerMetroplex clinical research centerAmsterdam university medical centerSystemic lupus erythematosus national assessmentMedical centerSyndrome disease activity indexTexas southwestern medical center